Kemwell Biopharma is one of India's largest biologics CDMOs, providing integrated drug substance and drug product development and manufacturing services from a single site in Bangalore. Established with technological support from a leading German biopharmaceutical company, Kemwell serves global pharma and biotech organizations with capabilities spanning monoclonal antibodies, complex fusion proteins, recombinant proteins, and bispecific antibodies. The company has received U.S. FDA approval for commercial drug product manufacturing and operates hybrid biomanufacturing with both stainless steel and single-use bioreactor systems.
biologics CDMO, monoclonal antibodies, fusion proteins, bispecific antibodies, recombinant proteins, drug substance and drug product manufacturing from single site, upstream/downstream bioprocessing
1 site worldwide
No reviews available yet.
No documents available.